ImmuCell reports mixed Q4 2025 results, pauses Re-Tain development

Go back to ImmuCell reports mixed Q4 2025 results, pauses Re-Tain development
Immucell Corp (NASDAQ: ICCC) Delayed: 10.98 +0.03 (0.27%)
Previous Close $10.95    52 Week High $8.29 
Open $10.80    52 Week Low $4.99 
Day High $11.06    P/E 137.25 
Day Low $10.47    EPS $0.08 
Volume 26,829